Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets
Latest news on PFIZER INC
10/19 PFIZER : Centreone Expands Contract Manufacturing To Nagoya, Japan
10/19 PFIZER : Biopharmaceutical Industry Creates Economic Opportunity for Americans
10/19 PFIZER : EDGE board approves incentives to entice Amazon warehouse, Pfizer jobs
10/18 PFIZER : Pfizers lorlatinib impresses in Phase II lung cancer trial
10/18 PFIZER INC. : Phase II Clinical Trial Of Lorlatinib Shows Promise
10/18 PFIZER : Pfizers son of Xalkori impresses in phase 2 NSCLC trial
10/18 PFIZER : Presents Full Results from Phase 2 Study of Next Generation Investigati..
10/18 PFIZER INC. : - New Ulcerative Colitis Data for XELJANZ at Upcoming Gastroentero..
10/18 RECKITT BENCKISER : to form two business units for better focus
10/17 PFIZER INC. (NYSE : PFE) Phase II Clinical Trial Of Lorlatinib Shows Promise
10/17 PFIZER : Presents Full Results From Phase 2 Study of Next-Generation Investigati..
10/17 PFIZER : New Ulcerative Colitis Data For Xeljanz (Tofacitinib) At Upcoming Gastr..
10/17 PFIZER : After getting skunked by rivals, Pfizer touts breakthrough cancer drug ..
10/17 PFIZER INC. : - The Union for International Cancer Control and Pfizer award
10/17DJDaimler Charts Leaner Approach -- WSJ
10/16 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 PFIZER : Presents Full Results from Phase 2 Study of Next-Generation Investigati..
10/16 PFIZER INC. : - U.S. FDA Approves LYRICA CR Extended Release Tablets CV
10/16 Stocks mostly up
10/15 FG : Ignorance Responsible for High Cancer Mortality Rate
10/14 PFIZER : Union for International Cancer Control, Pfizer Award New Round of Grant..
10/14 PFIZER : PFE) Shareholder Nordea Investment Management Ab Has Boosted Position
10/14 PFIZER : FG - Ignorance Responsible for High Cancer Mortality Rate
10/13 PFIZER : and Glaxo may find romance over the counter with consumer goods deal
10/13 PFIZER : The Union for International Cancer Control and Pfizer award new round o..
10/13 PFIZER : U.S. FDA Approves Lyrica CR (Pregabalin) Extended-Release Tablets CV
10/13 PFIZER INC. (NYSE : PFE) Lyrica CR Approved By FDA As Patent Expiry Date Nears
10/13 PFIZER : Brazil, Russia And India Offer The Best Opportunities In The Musculoske..
10/13 PFIZER : Announces FDA Approval Of LYRICA CR Extended-release Tablets CV
10/13 PFIZER : CordenPharma Acquires Pfizer API Manufacturing Facility in Boulder Colo..
10/13 PFIZER : U.S. FDA Approves LYRICA CR (Pregabalin) Extended-Release Tablets CV
10/12 PFIZER : Ian Hoban Joins Pilatus Clinical Services
10/12 PFIZER : reviewing alternatives for consumer healthcare business
10/12 PFIZER : Research Data from Pfizer Update Understanding of Biochemistry (The Axl..
10/12 PFIZER : Study Results from Pfizer Broaden Understanding of Crohn's Disease (Ant..
10/12 PFIZER : Findings from Pfizer Provide New Insights into Organic Research [Develo..
10/12 PFIZER : Patent Application Titled "2-Thiopyrimidinones" Published Online (USPTO..
10/12 PFIZER : Studies from Pfizer Further Understanding of Hexosyltransferases (Quant..
10/12 FINDINGS FROM PFIZER PROVIDES NEW DA : A Review of the Role of Budget Impact Ana..
10/12 PFIZER : U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV
10/12 PFIZER : Corporate News Blog - Pharma Giant Pfizer Mulling Divestment of Consume..
10/12 PFIZER : Partnering with The Boston Globe`s Brand Content Studio on a Series Cal..
10/12 PFIZER : Reviewing Strategic Alternatives for Consumer Healthcare Business
10/12 PFIZER : How to Create an Integrated Social Media and Digital Strategy for Patie..
10/11 PFIZER : mulls sale of consumer health business
10/11 PFIZER : Considers Spinning Off or Selling Consumer Health Unit
10/11 WENDYS : New york
10/11DJPFIZER : Tightens Focus on Prescription Drugs -- WSJ
10/11DJCompanies Chase Spinoff Bump -- WSJ
10/11 PFIZER : considers selling division Pfizer considers selling consumer business u..
10/11 PFIZER : US pharma giant Pfizer mulls sale of consumer healthcare business
10/10DJPFIZER : Considers a Sale or Spinoff of Its Consumer Healthcare Business -Update
10/10 PFIZER : Should you invest in Facebook, Helios and Matheson Analytics Inc, Nokia..
10/10 PFIZER : considers consumer business sale
10/10DJPFIZER : Reviews Consumer Healthcare Business Options; Could Include Spinoff or ..
10/10 PFIZER : may sell consumer unit
10/10 PFIZER : Reviewing Strategic Alternatives for Consumer Healthcare Business
10/10 PROCTER & GAMBLE : Business Highlights
10/10 PFIZER : considers sale of consumer business
10/09 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
10/09 EYE HEALTH SUPPLEMENTS MARKET : Improving in Healthcare Industry and Global Futu..
10/09 Pfizer Inc. AmerisourceBergen, Blue Cross Blue Shield Association
10/09 PFIZER : Launches novel programs to put important support services at the finger..
10/09 Stocks mostly up
10/09 Goal's health, not just profit
10/07 PFIZER : AMCP Foundation and Pfizer Offered Eight Summer Internships in Managed ..
10/06 PFIZER : DRGT announces results of Phase I study expanding clinical utility of t..
10/06 PFIZER : Launches Novel Programs to Put Important Support Services At Fingertips..
10/06 AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Thera..
10/06 ROCHE : Aspen welcomes decision to drop price probe
10/06 CONTRAFECT : Appoints Lisa Ricciardi as Chief Operating Officer
10/06 PFIZER : MD Anderson Cancer Center, Pfizer to Jointly Investigate Therapies for ..
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 52 676 M
EBIT 2017 19 837 M
Net income 2017 12 051 M
Debt 2017 24 101 M
Yield 2017 3,58%
P/E ratio 2017 19,26
P/E ratio 2018 16,94
EV / Sales 2017 4,51x
EV / Sales 2018 4,31x
Capitalization 213 B
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 38,2 $
Spread / Average Target 6,6%
EPS Revisions
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Dennis Arthur Ausiello Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON22.11%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER10.31%213 372